Although a small number of
repurposed and new
drugs have recently become
available to treat
drug - resistant TB (including bedaquiline, delamanid, and linezolid), the authors warn that without accurate diagnostic tests to deliver individually targeted treatments, clear prescription guidelines on appropriate use and improved control efforts to prevent transmission, optimal dosing and administration, and well - functioning health care systems, the effectiveness of the
drugs could be rapidly lost.